However, the major active compound in BB, TUDCA failed to restore the SOD levels in rats with liver fibrosis (p > 0.05), which indicated that a different mechanism might be involved in the anti-fibrotic action of TUDCA (Figure 3B). This evidence concerns the gene SOD1 and Hepatic fibrosis.